Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ABSK-043 by Abbisko Therapeutics for Solid Tumor: Likelihood of Approval
ABSK-043 is under clinical development by Abbisko Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Data Insights
ABSK-043 by Abbisko Therapeutics for Melanoma: Likelihood of Approval
ABSK-043 is under clinical development by Abbisko Therapeutics and currently in Phase I for Melanoma. According to GlobalData, Phase I...